119 related articles for article (PubMed ID: 37263155)
1. Visual impairment due to retinopathy of prematurity and concomitant disabilities in the Netherlands.
Trzcionkowska K; Termote JUM; van Genderen MM; de Vries MJ; van Sorge AJ; Schalij-Delfos NE
Early Hum Dev; 2023 Jul; 182():105793. PubMed ID: 37263155
[TBL] [Abstract][Full Text] [Related]
2. The incidence of visually impaired children with retinopathy of prematurity and their concomitant disabilities.
Termote J; Schalij-Delfos NE; Donders AR; Cats BP
J AAPOS; 2003 Apr; 7(2):131-6. PubMed ID: 12736627
[TBL] [Abstract][Full Text] [Related]
3. The incidence of visual impairment due to retinopathy of prematurity (ROP) and concomitant disabilities in the Netherlands: a 30 year overview.
van Sorge AJ; Termote JU; de Vries MJ; Boonstra FN; Stellingwerf C; Schalij-Delfos NE
Br J Ophthalmol; 2011 Jul; 95(7):937-41. PubMed ID: 21310801
[TBL] [Abstract][Full Text] [Related]
4. Nationwide inventory on retinopathy of prematurity screening in the Netherlands.
Trzcionkowska K; Termote JU; Böhringer S; van Sorge AJ; Schalij-Delfos N
Br J Ophthalmol; 2023 May; 107(5):712-716. PubMed ID: 34893474
[TBL] [Abstract][Full Text] [Related]
5. Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity?
Amer M; Jafri WH; Nizami AM; Shomrani AI; Al-Dabaan AA; Rashid K
Br J Ophthalmol; 2012 Aug; 96(8):1052-5. PubMed ID: 22649086
[TBL] [Abstract][Full Text] [Related]
6. Cost and effects of risk factor guided screening strategies for retinopathy of prematurity for different treatment strategies.
van den Akker-van Marle ME; van Sorge AJ; Schalij-Delfos NE
Acta Ophthalmol; 2015 Dec; 93(8):706-12. PubMed ID: 26149829
[TBL] [Abstract][Full Text] [Related]
7. Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017.
Trzcionkowska K; Vehmeijer WBHJ; Kerkhoff FT; Bauer NJC; Bennebroek CAM; Dijk PH; Dijkman KP; van den Dungen FAM; Eggink CA; Feenstra RPG; Groenendaal F; van Heijst AF; van der Hoeven MAHBM; Kornelisse RF; Kraal-Biezen E; Lopriore E; Onland W; Renardel de Lavalette VW; van Rijn LJ; Schuerman FABA; Simonsz HJ; Voskuil-Kerkhof ESM; Witlox RSGM; Termote JUM; Schalij-Delfos NE
Acta Ophthalmol; 2021 Feb; 99(1):97-103. PubMed ID: 32701185
[TBL] [Abstract][Full Text] [Related]
8. Cost reduction in screening for retinopathy of prematurity in the Netherlands by comparing different screening strategies.
Trzcionkowska K; Schalij-Delfos NE; van den Akker-van Marle EME
Acta Ophthalmol; 2023 Feb; 101(1):81-90. PubMed ID: 35751446
[TBL] [Abstract][Full Text] [Related]
9. Screening for retinopathy of prematurity in China: a neonatal units-based prospective study.
Xu Y; Zhou X; Zhang Q; Ji X; Zhang Q; Zhu J; Chen C; Zhao P
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8229-36. PubMed ID: 24204053
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and modification of French screening guidelines for retinopathy of prematurity.
Barjol A; Lux AL; Dureau P; Chapron T; Metge F; Abdelmassih Y; Caputo G
Acta Ophthalmol; 2022 Nov; 100(7):e1451-e1454. PubMed ID: 35080805
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Retinopathy of Prematurity in the Netherlands: A Comparison of Two Cohorts.
Trzcionkowska K; Groenendaal F; Andriessen P; Dijk PH; van den Dungen FAM; van Hillegersberg JL; Koole S; Kornelisse RF; van Westering-Kroon E; von Lindern JS; Meijssen CB; Schuerman FABA; Steiner K; van Tuyl MWG; Witlox RSGM; Schalij-Delfos NE; Termote JUM
Neonatology; 2021; 118(4):462-469. PubMed ID: 34293743
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Severe Visual Disability Among Preterm Children With Retinopathy of Prematurity and Association With Adherence to Best Practice Guidelines.
Norman M; Hellström A; Hallberg B; Wallin A; Gustafson P; Tornqvist K; Håkansson S; Holmström G
JAMA Netw Open; 2019 Jan; 2(1):e186801. PubMed ID: 30646195
[TBL] [Abstract][Full Text] [Related]
13. Incidence of retinopathy of prematurity over the last decade in the Central Netherlands.
Hoogerwerf A; Schalij-Delfos NE; van Schooneveld MJ; Termote JU
Neonatology; 2010; 98(2):137-42. PubMed ID: 20150751
[TBL] [Abstract][Full Text] [Related]
14. Visual impairment due to retinopathy of prematurity (ROP) in New Zealand: a 22-year review.
Tan Z; Chong C; Darlow B; Dai S
Br J Ophthalmol; 2015 Jun; 99(6):801-6. PubMed ID: 25527692
[TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units.
Bas AY; Demirel N; Koc E; Ulubas Isik D; Hirfanoglu İM; Tunc T;
Br J Ophthalmol; 2018 Dec; 102(12):1711-1716. PubMed ID: 29519879
[TBL] [Abstract][Full Text] [Related]
16. Incidence of retinopathy of prematurity treatment in extremely preterm infants in China.
Dai Y; Zhu L; Zhou Y; Wu Y; Chen D; Wang R; Wu L; Guo S; Gao L; Xu P; Wang Y; Dong S; Liu N; Wu Y; Chen H; Sun Y; Chen C; Zhang S
Paediatr Perinat Epidemiol; 2022 May; 36(3):380-389. PubMed ID: 34467552
[TBL] [Abstract][Full Text] [Related]
17. Retinopathy screening results of late-preterm infants born at 32-35 weeks of gestational age.
Tiryaki Demir S; Karapapak M; Uslu HS; Bulbul A; Guven D; Dirim AB; Ustaoglu M; Sendul SY; Olgun A
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1325-1329. PubMed ID: 30915536
[TBL] [Abstract][Full Text] [Related]
18. Neonatal Intensive Care Unit-based screening program for retinopathy of prematurity and its treatment in an Indian population.
Goyal A; Giridhar A; Gopalakrishnan M; Thachil T
Indian J Ophthalmol; 2019 Jun; 67(6):828-833. PubMed ID: 31124496
[TBL] [Abstract][Full Text] [Related]
19. Retinopathy of prematurity: are we screening too many babies?
Mathew MR; Fern AI; Hill R
Eye (Lond); 2002 Sep; 16(5):538-42. PubMed ID: 12194065
[TBL] [Abstract][Full Text] [Related]
20. Retinopathy of prematurity in Korean infants with birthweight greater than 1500 g.
Park SH; Yum HR; Kim S; Lee YC
Br J Ophthalmol; 2016 Jun; 100(6):834-8. PubMed ID: 26483442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
